Accession Number: | 0001214659-21-001205 |
Date: | 2021-02-02 |
Issuer: | MIRATI THERAPEUTICS, INC. (MRTX) |
Original Submission Date: |
FAGA DANIEL
C/O MIRATI THERAPEUTICS
9393 TOWNE CENTRE DRIVE SUITE 200
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-02-02 | M | 1,340 | a | $114.33 | 31,978 | direct | ||
COMMON STOCK | 2021-02-02 | S | 1,340 | d | $194.38 | 30,638 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON QUALIFIED STOCK OPTION (RIGHT TO BUY) | 114.33 | 2021-02-02 | deemed execution date | M | 1,340 (d) | 2030-01-05 | common stock 1,340 | $114.33 | 63,630 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on november 20, 2020. |
f2 | 1/4th of the shares subject to the option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the option shall vest each month thereafter until fully vested. |